Pharmacokinetically guided dosing has the potential to improve real-world outcomes of pazopanib.

导出原文传递

翻译打印收藏纠错

第一作者： Masahide,Fukudo

第一单位： Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.;Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.

作者： Masahide,Fukudo ^[1] ; Gaku,Tamaki ^[2] ; Makoto,Azumi ^[2] ; Hiroaki,Shibata ^[3] ; Susumu,Tandai ^[3]

作者单位： Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.;Department of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan. ^[1] Department of Renal and Urologic Surgery, Asahikawa Medical University, Asahikawa, Japan. ^[2] Department of Orthopedic Surgery, Asahikawa Medical University, Asahikawa, Japan. ^[3]

关键词 individualized dosing pazopanib, pharmacokinetics therapeutic drug monitoring

主题词药物监测(Drug Monitoring);人类(Humans);吲唑类(Indazoles);前瞻性研究(Prospective Studies);嘧啶类(Pyrimidines);磺胺类(Sulfonamides)

DOI 10.1111/bcp.14580

PMID 33010046

发布时间 2021-07-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交